Business Description
![Capricor Therapeutics Inc Capricor Therapeutics Inc logo](https://static.gurufocus.com/logos/0C00000VFE.png?14)
Capricor Therapeutics Inc
NAICS : 325414
SIC : 2836
ISIN : US14070B1017
Description
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 19.75 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | -0.08 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -2.5 | |||||
Beneish M-Score | 0.91 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 260.9 | |||||
3-Year EBITDA Growth Rate | 0.4 | |||||
3-Year EPS without NRI Growth Rate | -0.5 | |||||
3-Year FCF Growth Rate | -14.9 | |||||
3-Year Book Growth Rate | -19.1 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.73 | |||||
9-Day RSI | 42.79 | |||||
14-Day RSI | 41.52 | |||||
6-1 Month Momentum % | 16.16 | |||||
12-1 Month Momentum % | 18.83 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.57 | |||||
Quick Ratio | 1.57 | |||||
Cash Ratio | 1.51 | |||||
Days Sales Outstanding | 33.36 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.8 | |||||
Shareholder Yield % | -17.71 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -96.54 | |||||
Net Margin % | -89.73 | |||||
FCF Margin % | -123.01 | |||||
ROE % | -252.3 | |||||
ROA % | -49.58 | |||||
ROIC % | -76.53 | |||||
ROC (Joel Greenblatt) % | -358.09 | |||||
ROCE % | -158.85 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.05 | |||||
PB Ratio | 8.14 | |||||
Price-to-Tangible-Book | 8.14 | |||||
EV-to-EBIT | -4.49 | |||||
EV-to-Forward-EBIT | -2.73 | |||||
EV-to-EBITDA | -4.7 | |||||
EV-to-Forward-EBITDA | -2.73 | |||||
EV-to-Revenue | 4.34 | |||||
EV-to-Forward-Revenue | 6.35 | |||||
EV-to-FCF | -3.51 | |||||
Price-to-Median-PS-Value | 0.31 | |||||
Price-to-Net-Current-Asset-Value | 14.3 | |||||
Price-to-Net-Cash | 16.86 | |||||
Earnings Yield (Greenblatt) % | -22.27 | |||||
FCF Yield % | -22.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CAPR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Capricor Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 27.098 | ||
EPS (TTM) ($) | -0.83 | ||
Beta | 0.85 | ||
Volatility % | 122.07 | ||
14-Day RSI | 41.52 | ||
14-Day ATR ($) | 0.353108 | ||
20-Day SMA ($) | 5.0915 | ||
12-1 Month Momentum % | 18.83 | ||
52-Week Range ($) | 2.68 - 8.2212 | ||
Shares Outstanding (Mil) | 31.98 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Capricor Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Capricor Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Capricor Therapeutics Inc Frequently Asked Questions
What is Capricor Therapeutics Inc(CAPR)'s stock price today?
The current price of CAPR is $4.72. The 52 week high of CAPR is $8.22 and 52 week low is $2.68.
When is next earnings date of Capricor Therapeutics Inc(CAPR)?
The next earnings date of Capricor Therapeutics Inc(CAPR) is 2024-08-07 Est..
Does Capricor Therapeutics Inc(CAPR) pay dividends? If so, how much?
Capricor Therapeutics Inc(CAPR) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |